These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28848346)

  • 21. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
    Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
    Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of combination glycyrrhiizin and triptolide on TNF-alpha and IL-10 in serum of collagen induced arthritis rats].
    Zhang WD; Lu C; Zhao HY; Chen SL; Yang DJ; Lu AP
    Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(5):414-7. PubMed ID: 17511148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
    Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
    Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA-137/Notch1 pathway.
    Han F; Wang S; Chang Y; Li C; Yang J; Han Z; Chang B; Sun B; Chen L
    J Cell Physiol; 2018 Mar; 233(3):2225-2237. PubMed ID: 28695984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation-Responsive Mesoporous Silica Nanoparticles with Synergistic Anti-inflammatory and Joint Protection Effects for Rheumatoid Arthritis Treatment.
    Wu YZ; Chen WY; Zeng Y; Ji QL; Yang Y; Guo XL; Wang X
    Pharm Res; 2024 Jul; 41(7):1493-1505. PubMed ID: 38918308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
    Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
    Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer.
    Wang Y; Liu T; Li H
    J Biomater Sci Polym Ed; 2016; 27(7):545-56. PubMed ID: 26786618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triptolide Improves Diabetic Nephropathy by Regulating Th Cell Balance and Macrophage Infiltration in Rat Models of Diabetic Nephropathy.
    Guo H; Pan C; Chang B; Wu X; Guo J; Zhou Y; Liu H; Zhu Z; Chang B; Chen L
    Exp Clin Endocrinol Diabetes; 2016 Jun; 124(6):389-98. PubMed ID: 27328403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of galactosylated albumin for targeted delivery of triptolide to suppress hepatocellular carcinoma progression through inhibiting de novo lipogenesis.
    Yu L; Qian J; Xue X; Pang M; Wang X; Li X; Tian M; Lu C; Xiao C; Liu Y
    Biomed Pharmacother; 2024 Oct; 179():117432. PubMed ID: 39255735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo.
    Zhang L; Wang T; Li Q; Huang J; Xu H; Li J; Wang Y; Liang Q
    Int J Nanomedicine; 2016; 11():2663-73. PubMed ID: 27354796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategy for osteoarthritis therapy: Improved the delivery of triptolide using liposome-loaded dissolving microneedle arrays.
    Zhou P; Chen C; Yue X; Zhang J; Huang C; Zhao S; Wu A; Li X; Qu Y; Zhang C
    Int J Pharm; 2021 Nov; 609():121211. PubMed ID: 34687817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triptolide Modulates TREM-1 Signal Pathway to Inhibit the Inflammatory Response in Rheumatoid Arthritis.
    Fan D; He X; Bian Y; Guo Q; Zheng K; Zhao Y; Lu C; Liu B; Xu X; Zhang G; Lu A
    Int J Mol Sci; 2016 Apr; 17(4):498. PubMed ID: 27049384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [TLR4/NF-kappaB p65 signaling pathway mediates protective effect of triptolide on endothelium in rats with endotoxemia].
    Zong JQ; Wang SY; Su P; Sun BB; Guo MD; Diao GH; Wang J; Wang HH
    Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4912-4917. PubMed ID: 31872600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide-targeted delivery methods.
    Xu H; Liu B
    Eur J Med Chem; 2019 Feb; 164():342-351. PubMed ID: 30605832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of poly(D, L-lactic acid) nanoparticles as triptolide carrier on abating rats renal toxicity by NMR-based metabolic analysis.
    Liu M; Dong J; Yang Y; Yang X; Xu H
    J Nanosci Nanotechnol; 2008 Jul; 8(7):3493-9. PubMed ID: 19051901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and subacute toxicity studies on triptolide and triptolide-loaded polymeric micelles following intravenous administration in rodents.
    Xu L; Qiu Y; Xu H; Ao W; Lam W; Yang X
    Food Chem Toxicol; 2013 Jul; 57():371-9. PubMed ID: 23583804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and optimization of triptolide-loaded solid lipid nanoparticles for oral delivery with reduced gastric irritation.
    Zhang C; Gu C; Peng F; Liu W; Wan J; Xu H; Lam CW; Yang X
    Molecules; 2013 Oct; 18(11):13340-56. PubMed ID: 24172242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
    Gu Y; Tang X; Yang M; Yang D; Liu J
    Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity.
    Zheng W; Wang C; Ding R; Huang Y; Li Y; Lu Y
    Int J Pharm; 2019 Dec; 572():118721. PubMed ID: 31626922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triptolide and atorvastatin synergistically promote hepatotoxicity in cultured hepatocytes and female Sprague-Dawley rats by inhibiting pregnane X receptor-mediated transcriptional activation of CYP3A4.
    Zheng N; Wei A; Wu T; Long L; Yang H; Li H; Wang L
    Toxicol Lett; 2021 May; 342():85-94. PubMed ID: 33600922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.